Helen Mary Ginn

Helen Mary Ginn

Auto-generated profile, based on publicly available information

Helen Mary Ginn

Center for Free-Electron Laser Science CFEL, Deutsches Elektronen-Synchrotron DESY

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Cell
Verified
Journal Article
Open access
WDWanwisa Dejnirattisai
Wanwisa Dejnirattisai
DZDaming Zhou
Daming Zhou
HGHelen M. Ginn
Helen M. Ginn
HDHelen M.E. Duyvesteyn
Helen M.E. Duyvesteyn
PSPiyada Supasa
Piyada Supasa
GSGavin R. Screaton
Gavin R. Screaton
Antibodies are crucial to immune protection against SARS-CoV-2, with some in emergency use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) recognizing the virus spike and focus mainly on 80 that bind the receptor binding domain (RBD). We devise a competition data-driven method to map RBD binding sites. We find that although antibody binding sites are widely dispersed, neutralizing antibody binding is focused, with nearly all highly inhibitory mAbs (IC50 < 0.1 μg/mL) blocking receptor interaction, except for one that binds a unique epitope in the N-terminal domain. Many of these neutralizing mAbs use public V-genes and are close to germline. We dissect the structural basis of recognition for this large panel of antibodies through X-ray crystallography and cryoelectron microscopy of 19 Fab-antigen structures. We find novel binding modes for some potently inhibitory antibodies and demonstrate that strongly neutralizing mAbs protect, prophylactically or therapeutically, in animal models.

7 May 2021 in Science
Verified
Journal Article
Open access
PDF file
SGSebastian Guenther
Sebastian Guenther
PRPatrick Y. A. Reinke
Patrick Y. A. Reinke
YFYaiza Fernández-García
Yaiza Fernández-García
JLJulia Lieske
Julia Lieske
TLThomas J. Lane
Thomas J. Lane
AMAlke Meents
Alke Meents
A large-scale screen to target SARS-CoV-2: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome is initially expressed as two large polyproteins. Its main protease, M pro , is essential to yield functional viral proteins, making it a key drug target. Günther et al. used x-ray crystallography to screen more than 5000 compounds that are either approved drugs or drugs in clinical trials. The screen identified 37 compounds that bind to M pro . High-resolution structures showed that most compounds bind at the active site but also revealed two allosteric sites where binding of a drug causes conformational changes that affect the active site. In cell-based assays, seven compounds had antiviral activity without toxicity. The most potent, calpeptin, binds covalently in the active site, whereas the second most potent, pelitinib, binds at an allosteric site. Science , this issue p. 642

27 July 2016 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Open access
PDF file
SOSaeed Oghbaey
Saeed Oghbaey
ASAntoine Sarracini
Antoine Sarracini
HGHelen M. Ginn
Helen M. Ginn
OPOlivier Pare-Labrosse
Olivier Pare-Labrosse
AKAnling Kuo
Anling Kuo
RMR. J. Dwayne Miller
R. J. Dwayne Miller
The advent of ultrafast highly brilliant coherent X-ray free-electron laser sources has driven the development of novel structure-determination approaches for proteins, and promises visualization of protein dynamics on sub-picosecond timescales with full atomic resolution. Significant efforts are being applied to the development of sample-delivery systems that allow these unique sources to be most efficiently exploited for high-throughput serial femtosecond crystallography. Here, the next iteration of a fixed-target crystallography chip designed for rapid and reliable delivery of up to 11 259 protein crystals with high spatial precision is presented. An experimental scheme for predetermining the positions of crystals in the chip by means ofin situspectroscopy using a fiducial system for rapid, precise alignment and registration of the crystal positions is presented. This delivers unprecedented performance in serial crystallography experiments at room temperature under atmospheric pressure, giving a raw hit rate approaching 100% with an effective indexing rate of approximately 50%, increasing the efficiency of beam usage and allowing the method to be applied to systems where the number of crystals is limited.

1 February 2018 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Open access
PDF file
JGJonathan M. Grimes
Jonathan M. Grimes
DHDavid R. Hall
David R. Hall
AAAlun W. Ashton
Alun W. Ashton
GEGwyndaf Evans
Gwyndaf Evans
RORobin L. Owen
Robin L. Owen
DSDavid Ian Stuart
David Ian Stuart
Macromolecular crystallography (MX) has been a motor for biology for over half a century and this continues apace. A series of revolutions, including the production of recombinant proteins and cryo-crystallography, have meant that MX has repeatedly reinvented itself to dramatically increase its reach. Over the last 30 years synchrotron radiation has nucleated a succession of advances, ranging from detectors to optics and automation. These advances, in turn, open up opportunities. For instance, a further order of magnitude could perhaps be gained in signal to noise for general synchrotron experiments. In addition, X-ray free-electron lasers offer to capture fragments of reciprocal space without radiation damage, and open up the subpicosecond regime of protein dynamics and activity. But electrons have recently stolen the limelight: so is X-ray crystallography in rude health, or will imaging methods, especially single-particle electron microscopy, render it obsolete for the most interesting biology, whilst electron diffraction enables structure determination from even the smallest crystals? We will lay out some information to help you decide.

28 July 2016 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Open access
PDF file
HGHelen Mary Ginn
Helen Mary Ginn
PRPhilip Roedig
Philip Roedig
AKAnling Kuo
Anling Kuo
GEGwyndaf Evans
Gwyndaf Evans
NSNicholas K. Sauter
Nicholas K. Sauter
DSDavid Ian Stuart
David Ian Stuart
The indexing methods currently used for serial femtosecond crystallography were originally developed for experiments in which crystals are rotated in the X-ray beam, providing significant three-dimensional information. On the other hand, shots from both X-ray free-electron lasers and serial synchrotron crystallography experiments are still images, in which the few three-dimensional data available arise only from the curvature of the Ewald sphere. Traditional synchrotron crystallography methods are thus less well suited to still image data processing. Here, a new indexing method is presented with the aim of maximizing information use from a still image given the known unit-cell dimensions and space group. Efficacy for cubic, hexagonal and orthorhombic space groups is shown, and for those showing some evidence of diffraction the indexing rate ranged from 90% (hexagonal space group) to 151% (cubic space group). Here, the indexing rate refers to the number of lattices indexed per image.

9 September 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
AEAustin Echelmeier
Austin Echelmeier
JVJorvani Cruz Villarreal
Jorvani Cruz Villarreal
Marc MesserschmidtMarc Messerschmidt
Marc Messerschmidt
DKDaihyun Kim
Daihyun Kim
JCJesse D. Coe
Jesse D. Coe
ARAlexandra Ros
Alexandra Ros
Serial femtosecond crystallography (SFX) with X-ray free electron lasers (XFELs) allows structure determination of membrane proteins and time-resolved crystallography. Common liquid sample delivery continuously jets the protein crystal suspension into the path of the XFEL, wasting a vast amount of sample due to the pulsed nature of all current XFEL sources. The European XFEL (EuXFEL) delivers femtosecond (fs) X-ray pulses in trains spaced 100 ms apart whereas pulses within trains are currently separated by 889 ns. Therefore, continuous sample delivery via fast jets wastes >99% of sample. Here, we introduce a microfluidic device delivering crystal laden droplets segmented with an immiscible oil reducing sample waste and demonstrate droplet injection at the EuXFEL compatible with high pressure liquid delivery of an SFX experiment. While achieving ~60% reduction in sample waste, we determine the structure of the enzyme 3-deoxy-D-manno-octulosonate-8-phosphate synthase from microcrystals delivered in droplets revealing distinct structural features not previously reported.